Monopar Therapeutics Inc - Rasio nilai perusahaan marang dodolan MNPR

Simbol resmi perusahaan monopartx.com (MNPR)

The development of targeted agents that destroy tumors from within shapes the financial profile of Monopar Therapeutics (MNPR). The current EV/Sales value on this chart shows that the metric stands at 0.00. Capital optimization is based on the market launch of radiopharmaceuticals and the success of oral cancer therapy, where a steady patient inflow and high efficacy await final FDA approval.

Monopar Corp (MNPR): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Monopar Pharma - rincian analitis lan metrik utama (MNPR)

Pambiji fundamental perusahaan:MNPR, monopartx.com
Produk sing diprodhuksi Monopar Therapeutics Inc

Investing in Monopar Therapeutics (MNPR) requires strict fundamental control due to the high volatility of the biotech sector. This indicator compares the total enterprise value, adjusted for net debt, against the volume of generated revenue. Analyzing the firm's valuation via the EV/Sales multiple allows for a real-time assessment of whether the asset is overbought. This is critical for Monopar Therapeutics (MNPR), as the risks of clinical failures and pressure from biosimilars could sharply impair capital. The trend of this metric helps avoid entering a position at local peaks.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Inhibrx Biosciences INBX|Nilai perusahaan marang pendapatan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Nilai bisnis marang pendapatan|Heron Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CRBP (Corbus Pharma)|CRDF: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan beyondspringpharma.com (BYSI)|Rasio nilai perusahaan marang pendapatan bioatla.com|LIXT: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CTXR|Multiplikator EV/Sales Cellectar Corp (CLRB)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales